World Health: Bioterrorism
TABLE OF CONTENTS
Volume 85, Issue 6 (June 2009)
Editorial |
News & Views |
Perspectives |
State of the Art |
Research |
Discovery & Development |
Regulation & Use
In This Issue
In This Issue
In This Issue
Clin Pharmacol Ther 85: 559; doi:10.1038/clpt.2009.58
See also: Opinion by SeiterSee also: State of the Art by Olliaro & WellsSee also: Article by Murray et al. See also: Article by Doherty & TurnerSee also: Article by Maher & LushniakEditorial
World Health and Bioterrorism
J Vincent
Clin Pharmacol Ther 85: 561-565; doi:10.1038/clpt.2009.73
News & Views
Highlights
Highlights
Clin Pharmacol Ther 85: 566-567; doi:10.1038/clpt.2009.59
ASCPT News
ASCPT News
Clin Pharmacol Ther 85: 568-569; doi:10.1038/clpt.2009.67
Perspectives
Point/Counterpoint
Drug and Vaccine Development for Infectious Diseases: The Value of Priority Review Vouchers
J Matheny, B Smith, B Courtney and M Mair
Clin Pharmacol Ther 85: 571-572; doi:10.1038/clpt.2009.53
See also: Point/Counterpoint by KesselheimPriority Review Vouchers: An Inefficient and Dangerous Way to Promote Neglected-Disease Drug Development
AS Kesselheim
Clin Pharmacol Ther 85: 573-575; doi:10.1038/clpt.2009.50
See also: Point/Counterpoint by Matheny et al.Opinion
Health and Economic Consequences of Counterfeit Drugs
A Seiter
Clin Pharmacol Ther 85: 576-578; doi:10.1038/clpt.2009.47
Commentaries
Global Challenges for Clinical Pharmacology in the Developing World
TF Blaschke
Clin Pharmacol Ther 85: 579-581; doi:10.1038/clpt.2009.54
Can the Selection and Use of Essential Medicines Decrease Inappropriate Drug Use?
MM Reidenberg
Clin Pharmacol Ther 85: 581-583; doi:10.1038/clpt.2009.10
State of the Art
State of the Art
The Global Portfolio of New Antimalarial Medicines Under Development
P Olliaro and TNC Wells
Clin Pharmacol Ther 85: 584-595; advance online publication, April 29, 2009; doi:10.1038/clpt.2009.51
Research
Reports
The Risk of Motor Vehicle Accidents Involving Drivers With Prescriptions for Codeine or Tramadol
LC Bachs, A Engeland, JG Mørland and S Skurtveit
Clin Pharmacol Ther 85: 596-599; advance online publication, March 11, 2009; doi:10.1038/clpt.2009.14
Articles
Time-to-Signal Comparison for Drug Safety Data-Mining Algorithms vs. Traditional Signaling Criteria
AM Hochberg and M Hauben
Clin Pharmacol Ther 85: 600-606; advance online publication, March 25, 2009; doi:10.1038/clpt.2009.26
Are We Optimizing Gestational Diabetes Treatment With Glyburide? The Pharmacologic Basis for Better Clinical Practice
MF Hebert, X Ma, SB Naraharisetti, KM Krudys, JG Umans, GDV Hankins, SN Caritis, M Miodovnik, DR Mattison, JD Unadkat, EJ Kelly, D Blough, C Cobelli, MS Ahmed, WR Snodgrass, DB Carr, TR Easterling and P Vicini for the Obstetric-Fetal Pharmacology Research Unit Network
Clin Pharmacol Ther 85: 607-614; advance online publication, March 18, 2009; doi:10.1038/clpt.2009.5
Personalized Dosing of Cyclophosphamide in the Total Body Irradiation–Cyclophosphamide Conditioning Regimen: A Phase II Trial in Patients With Hematologic Malignancy
JS McCune, A Batchelder, KA Guthrie, R Witherspoon, FR Appelbaum, B Phillips, P Vicini, DH Salinger and GB McDonald
Clin Pharmacol Ther 85: 615-622; advance online publication, March 18, 2009; doi:10.1038/clpt.2009.27
Pharmacokinetics of Raltegravir in Individuals With UGT1A1 Polymorphisms
LA Wenning, AS Petry, JT Kost, B Jin, SA Breidinger, I DeLepeleire, EJ Carlini, S Young, T Rushmore, F Wagner, NM Lunde, F Bieberdorf, H Greenberg, JA Stone, JA Wagner and M Iwamoto
Clin Pharmacol Ther 85: 623-627; advance online publication, March 11, 2009; doi:10.1038/clpt.2009.12
Dose-Dependent Acute and Sustained Renal Effects of the Endothelin Receptor Antagonist Avosentan in Healthy Subjects
J Smolander, B Vogt, M Maillard, C Zweiacker, T Littke, T Hengelage and M Burnier
Clin Pharmacol Ther 85: 628-634; advance online publication, March 11, 2009; doi:10.1038/clpt.2009.15
Association of Nicotine Metabolite Ratio and CYP2A6 Genotype With Smoking Cessation Treatment in African-American Light Smokers
MK Ho, JC Mwenifumbo, N Al Koudsi, KS Okuyemi, JS Ahluwalia, NL Benowitz and RF Tyndale
Clin Pharmacol Ther 85: 635-643; advance online publication, March 11, 2009; doi:10.1038/clpt.2009.19
Short-Term Clarithromycin Administration Impairs Clearance and Enhances Pharmacodynamic Effects of Trazodone but Not of Zolpidem
D Farkas, LP Volak, JS Harmatz, LL von Moltke, MH Court and DJ Greenblatt
Clin Pharmacol Ther 85: 644-650; advance online publication, February 25, 2009; doi:10.1038/clpt.2008.293
Factors Associated With Exacerbation of Heart Failure Include Treatment Adherence and Health Literacy Skills
MD Murray, W Tu, J Wu, D Morrow, F Smith and DC Brater
Clin Pharmacol Ther 85: 651-658; advance online publication, March 4, 2009; doi:10.1038/clpt.2009.7
Discovery & Development
Translational Medicine
Mass Drug Administration and Integrated Control for the World's High-Prevalence Neglected Tropical Diseases
PJ Hotez
Clin Pharmacol Ther 85: 659-664; advance online publication, March 25, 2009; doi:10.1038/clpt.2009.16
Development
Thinking About Broadly Cross-Reactive Vaccines
PC Doherty and SJ Turner
Clin Pharmacol Ther 85: 665-668; advance online publication, April 29, 2009; doi:10.1038/clpt.2009.52
